Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants
Clinical trial NCT02608853 · COMPLETED
Trial details
- NCT number
- NCT02608853
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-01-01
- Enrollment
- 9999
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.